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Herein is reported the clinical case of a nine-year-old female, second child of a non-consanguineous couple, born at term after an uneventful 
pregnancy and labor. The girl had regular growth and normal development, except for walking delay acquired at 24 months and recent school 
complaints about attention issues and reading difficulties. Regarding family history, the father had end-stage kidney disease without known 
cause and had been transplanted, one female cousin deceased at the age of eight years after central nervous system infection, and another 
female cousin aged 23 years had a neurodegenerative disease with onset after an infection (Fig. 1).
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Kidney	disease	
Neurological	disease	
The girl was transferred to the Intensive Care Unit with acute 
respiratory failure after a 24-hour period of cough, sweating, 
nocturnal agitation, and ill-being evolving to groan, noisy breathing, 
and perioral cyanosis. She had experienced respiratory arrest at home, 
requiring mouth-to-mouth resuscitation. At the emergency room, 
the girl presented polypnea, hypoxemia, tachycardia, and capillary 
refill time of four seconds with normal blood pressure, without fever. 
She was agitated, but neurological exam was otherwise normal. 
Physical exam showed crackles without wheezing. Leukocyte count 
was 41.000/ul with low C-reactive protein (9.7 mg/L) and chest x-ray 
displayed right lung pneumonia signs, for which she started empirical 
antibiotic treatment. She had progressive respiratory distress 
with respiratory acidosis and hypotension, requiring mechanical 
ventilation. Cardiac enzymes, creatine-kinase, and echocardiogram 
were normal. Microbiological exams were sterile and respiratory 
secretions were positive for Rhinovirus and Enterovirus.
Clinical evolution was favorable and the patient was extubated at 
hospitalization day three, after which nystagmus at horizontal gaze 
extremes, ophthalmoparesis with impaired lateral gaze, ataxia, and 
discrete dysarthria were noted. Careful symptom review identified 
episodes of cold extremities, sudoresis and transient skin color alteration, restlessness, irritability, and sleep disturbance in the past month, 
starting after a sore throat episode.
Brain magnetic resonance revealed symmetrical bilateral T2 hyperintensities on pons and midbrain and basal ganglia involving putamen and 
caudate (Fig. 2).
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DIAGNOSIS
Leigh syndrome, or subacute necrotizing encephalomyelopathy 
(MIM # 256000) 
Leigh syndrome, or subacute necrotizing encephalomyelopathy 
(MIM # 256000), is a neurodegenerative disease with characteristic 
neuroradiological features, including symmetrical T2 basal ganglia 
hyperintensities with or without brainstem involvement. It translates 
an energy metabolism disease with more than 75 known causing 
genes, located either on nuclear or mitochondrial genome.1 It is the 
most common presentation of mitochondrial disease in childhood, 
either related with nuclear or mitochondrial genome. Diagnostic 
criteria include: i) clinical brainstem and/or basal ganglia dysfunction, 
ii) intellectual and motor developmental delay, and iii) abnormal 
energy metabolism (severe defect in respiratory chain function or 
pyruvate dehydrogenase complex activity, molecular diagnosis in a 
mitochondrial energy-production gene, or elevated serum or CSF 
lactate).2
Leigh syndrome most often presents after a catabolic event, such 
as an infection, surgery, or fasting.1 Neurological involvement − as 
ataxia (basal ganglia) or acute respiratory insufficiency (brainstem 
involvement) − following such events should raise clinical suspicion 
of this diagnosis.1-3
In this patient, proband mitochondrial genetic analysis showed 
mitochondrial ATP synthase subunit 6 gene (MT-ATP6) m.8993T>G 
mutation in homoplasmy (>95% of mutated mtDNA copies). MT-ATP6 
gene codifies for a respiratory chain complex V subunit.3 Further 
analyses confirmed the same diagnosis in the patient’s cousin.
Acute neurological deterioration with movement disorder or 
respiratory failure in a patient with a catabolic event (infection with or 
What is your diagnosis? without fever, surgery, fasting, trauma, etc.) should raise suspicion of 
Leigh (-like) syndrome.4 In this case, pedigree analysis showing positive 
family history for individuals interconnected by females raised the 
possibility of a maternally inherited condition (mitochondrial DNA-
related disease). Together with Leigh syndrome diagnosis, a primary 
mitochondrial disorder related with mitochondrial DNA (mtDNA) was 
among the first diagnostic options. 
Leigh syndrome follow-up includes neurological, ophthalmological 
(risk of retinopathy), and renal (risk of tubulopathy) evaluation, 
although other mitochondrial disorder manifestations can occur.4 
After six years of follow-up, this patient showed emotional lability, 
hetero-aggressiveness periods, agitated sleep, and discrete ataxia, 
with no other brainstem dysfunction or development regression 
episodes besides developmental delay.
Genetic counseling for mitochondrial-DNA related disorders is 
extremely challenging. First, phenotype results from a combination of 
factors, including pathogenic variant severity, percentage of mutated 
mitochondria (mtDNA heteroplasmy), and tissue distribution, 
besides potential variants in other relevant genes that can modify 
phenotype (disease-modifying genes). Consequently, there is a wide 
phenotypic range even within the same family, ranging from mild 
to severe symptoms with varying age of onset. This makes virtually 
impossible to interpret asymptomatic at-risk family member test 
results in order to have phenotypic prediction. Moreover, absence 
of mtDNA pathogenic variants in one tissue (e.g. blood) does not 
guarantee its absence from other tissues (e.g. oocytes).5  Second, 
risk of recurrence in sibs depends on the mothers’ genetic status, as 
well as tissue distribution and abnormal mtDNA proportion. Proband 
mother usually has much lower abnormal mtDNA proportion than 
the proband and may be asymptomatic.5
Genetic counselling regarding reproductive options is also 
challenging. Prenatal testing (directly performed on biopsy cells, not 
cultured) can have conflicting results with an intermediate abnormal 
mtDNA proportion, with nearly impossible outcome prediction. 
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Figure 2 - A and B: Axial T2-weighted and T2 FLAIR basal ganglia images showing circumscribed and hyperintense lesions in the putamen 
and caudate nuclei. B: Axial T2-weighted brainstem image showing symmetrical involvement of the periaqueductal grey matter. C: Axial T1-
weighted image showing reduced signal in T2 abnormal areas. D: Axial T1 weighted image with gadolinium showing no significant contrast 
enhancement.
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Oocyte donation accompanied by in vitro fertilization using partner’s 
sperm can be an option; however, availability of donor oocytes is 
limited and personal or cultural issues may arise regarding the use 
of donor gametes. Preimplantation genetic diagnosis is currently 
considered the preferred reproductive option and can be used 
to transfer embryos with lower mutant mtDNA load, with low 
recurrence risk. Mitochondrial donation, in which nuclear material 
is transferred as pronucleus or maternal spindle from an unfertilized 
oocyte or single-cell embryo into an enucleated healthy donor cell 
(with unaffected mitochondria) could potentially block transmission 
of mutated mtDNA into the developing embryo.5 However, unlike 
countries such as the United Kingdom, this technique it is not 
currently available in Portugal. 
Overall, genetic counseling for mitochondrial genetic related 
disease presents considerable challenges. It requires multidisciplinary 
involvement with an up-to-date experienced team, to ensure that 
prospective parents are counseled regarding all potential outcomes 
and limitations of prenatal diagnosis or assisted reproduction.
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